Policy | Funding | Influence
Insights for changemakers on navigating government opportunities.
USAMRDC Capabilities Day 5-21-24
G2G regularly attends events at Fort Detrick, Maryland which is a hub for Department of Defense (DoD) aligned biomedical research and development. It serves as the headquarters of the U.S. Army Medical Research and Development Command (USAMRDC), whose mission centers on developing, acquiring and delivering medical capabilities for the warfighter.
Congress and the Appropriations Quagmire
The outlook is not looking good for closing out the FY24 appropriations process with a bipartisan deal by January 19 and February 2, when current funding measures expire. Here’s why.
G2G’s Women’s Health Innovation and Policy Insights
President Joe Biden & First Lady Dr. Jill Biden announce first-ever White House Initiative on Women’s Health Research , to be led by First Lady Jill Biden and the White House Gender Policy Council. This new initiative will focus on closing gaps in women’s health through accelerated, government-wide research efforts.
Congressional Briefing on Navigating Adult Vaccines – How They Impact Our Health and Economy
Given the recent COVID pandemic and the role vaccines have played in keeping it at bay, we invite you to see this special Congressional Briefing on vaccines with speakers from Harvard, Mass General and the research community. Watch our February 22, 2023 event!
BARDA Industry Day Report 2023
G2G participated in the annual Biomedical Advanced Research and Development Authority (BARDA) Industry Day.
THE GROUNDHOG DAY FEDERAL APPROPRIATIONS PROCESS
Federal Legislative Updates Ohio Legislative Updates G2G Blog Ever wonder if members of Congress are living in the movie Groundhog Day? Back to All Posts Ever wonder if members of…
Summary of the Government Biotechnology Innovation Summit
On September 27-28, G2G attended the Inaugural Government Biotechnology Innovation Summit in National Harbor, MD. The forum was centered on highlighting the ongoing whole of government approach towards bolstering the bioeconomy, biosecurity and national security, and opportunities for industry to engage with the government to meet these goals.
MHSRS Daily Digest Day 4 – Thursday, August 17
Each year, G2G attends the Military Health Systems Research Symposium (MHSRS) which brings together military, government, academia, and industry experts to share their latest research findings and challenges on topics, including combat casualty care, military operational medicine, clinical and rehabilitative medicine, medical simulation and information sciences, military infectious diseases, and the radiation health effects.
MHSRS Daily Digest Day 3 – Wednesday, August 16
Each year, G2G attends the Military Health Systems Research Symposium (MHSRS) which brings together military, government, academia, and industry experts to share their latest research findings and challenges on topics, including combat casualty care, military operational medicine, clinical and rehabilitative medicine, medical simulation and information sciences, military infectious diseases, and the radiation health effects.
MHSRS Daily Digest Day 2 – Tuesday, August 15
Each year, G2G attends the Military Health Systems Research Symposium (MHSRS) which brings together military, government, academia, and industry experts to share their latest research findings and challenges on topics, including combat casualty care, military operational medicine, clinical and rehabilitative medicine, medical simulation and information sciences, military infectious diseases, and the radiation health effects.
MHSRS Daily Digest Day 1 – Monday, August 14
Each year, G2G attends the Military Health Systems Research Symposium (MHSRS) which brings together military, government, academia, and industry experts to share their latest research findings and challenges on topics, including combat casualty care, military operational medicine, clinical and rehabilitative medicine, medical simulation and information sciences, military infectious diseases, and the radiation health effects.